Laden...
Dear Colleague, Will you be at the J.P. Morgan Healthcare Conference next month? If so, please join us for the FierceBiotech Executive Breakfast on January 8th at the Fairmont Hotel in San Francisco. This year's event will feature an all-new format with a full breakfast buffet, two panel discussions, and a coffee break. During Panel One, Rewiring R&D: The Promises of Digital, AI, and Machine Learning for Biotech Research, we will speak to key leaders from across the industry about how they are helping biopharmas speed up R&D while making it more accurate, and how to manage expectations against hype when it comes to digital health. Panel Two, Challenges and Solutions Around the Drug Pricing Debate, will explore the battle over drug pricing and will bring together experts and companies on all sides of the debate to talk about the challenges coming over the next few years and potential solutions. We also have a great lineup of speakers including: Andrew Allen M.D., Ph.D. / Co-Founder, President, and CEO / Gritstone Oncology Percival Barretto-Ko / President, Americas Operations / Astellas Alexis Borisy / Partner / Third Rock Ventures Ruud Dobber / Executive Vice President, North America / AstraZeneca US Kevin Julian / Senior Managing Director, Life Sciences / Accenture Daphne Koller / CEO / Insitro Saurabh Saha / Global Head of Translational Medicine / Bristol-Myers Squibb John Tsai / Head of Global Drug Development / Novartis Stephen J. Ubl / President and Chief Executive Officer / PhRMA Tony Wood / SVP Medicinal Science and Technology / GSKSeats are limited and Early Bird Rates end this Friday, December 7th, so don’t delay. Click here to register and reserve your spot at the event. I look forward to seeing you in San Francisco. Best, Rebecca Willumson |
Click here to unsubscribe or to manage your subscriptions. ©2018 FierceMarkets, a division of Questex, LLC. All rights reserved. 1900 L St NW | Washington, DC | 20036 www.questex.com |
Laden...
Laden...
© 2024